These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 19674539)

  • 21. Immunogenicity of the highly pathogenic porcine reproductive and respiratory syndrome virus GP5 protein encoded by a synthetic ORF5 gene.
    Li B; Xiao S; Wang Y; Xu S; Jiang Y; Chen H; Fang L
    Vaccine; 2009 Mar; 27(13):1957-63. PubMed ID: 19368777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge.
    Zuckermann FA; Garcia EA; Luque ID; Christopher-Hennings J; Doster A; Brito M; Osorio F
    Vet Microbiol; 2007 Jul; 123(1-3):69-85. PubMed ID: 17376612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discriminating between serological responses to European-genotype live vaccine and European-genotype field strains of porcine reproductive and respiratory syndrome virus (PRRSV) by peptide ELISA.
    Oleksiewicz MB; Stadejek T; Maćkiewicz Z; Porowski M; Pejsak Z
    J Virol Methods; 2005 Nov; 129(2):134-44. PubMed ID: 15992937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection.
    Opriessnig T; Madson DM; Prickett JR; Kuhar D; Lunney JK; Elsener J; Halbur PG
    Vet Microbiol; 2008 Sep; 131(1-2):103-14. PubMed ID: 18430525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus.
    Jiang Y; Fang L; Xiao S; Zhang H; Pan Y; Luo R; Li B; Chen H
    Vaccine; 2007 Jan; 25(3):547-60. PubMed ID: 16920232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity.
    Jiang Y; Xiao S; Fang L; Yu X; Song Y; Niu C; Chen H
    Vaccine; 2006 Apr; 24(15):2869-79. PubMed ID: 16446016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in mice.
    Jiang W; Jiang P; Li Y; Tang J; Wang X; Ma S
    Vet Immunol Immunopathol; 2006 Sep; 113(1-2):169-80. PubMed ID: 16777236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Similarity of European porcine reproductive and respiratory syndrome virus strains to vaccine strain is not necessarily predictive of the degree of protective immunity conferred.
    Prieto C; Alvarez E; Martínez-Lobo FJ; Simarro I; Castro JM
    Vet J; 2008 Mar; 175(3):356-63. PubMed ID: 17560818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive inductive effect of IL-2 on virus-specific cellular responses elicited by a PRRSV-ORF7 DNA vaccine in swine.
    Rompato G; Ling E; Chen Z; Van Kruiningen H; Garmendia AE
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):151-60. PubMed ID: 16162362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a DNA-launched replicon as a vaccine for porcine reproductive and respiratory syndrome virus.
    Pujhari S; Baig TT; Hansra S; Zakhartchouk AN
    Virus Res; 2013 May; 173(2):321-6. PubMed ID: 23353778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune responses of pigs immunized with a recombinant porcine reproductive and respiratory syndrome virus expressing porcine GM-CSF.
    Li Z; Wang G; Wang Y; Zhang C; Huang B; Li Q; Li L; Xue B; Ding P; Cai X; Wang C; Zhou EM
    Vet Immunol Immunopathol; 2015 Nov; 168(1-2):40-8. PubMed ID: 26300317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pigs immunized with Chinese highly pathogenic PRRS virus modified live vaccine are protected from challenge with North American PRRSV strain NADC-20.
    Galliher-Beckley A; Li X; Bates JT; Madera R; Waters A; Nietfeld J; Henningson J; He D; Feng W; Chen R; Shi J
    Vaccine; 2015 Jul; 33(30):3518-25. PubMed ID: 26049004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of an inactivated vaccine against porcine reproductive and respiratory syndrome to protect gilts against a heterologous challenge with PRRSV.
    Scortti M; Prieto C; Alvarez E; Simarro I; Castro JM
    Vet Rec; 2007 Dec; 161(24):809-13. PubMed ID: 18083979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The assessment of efficacy of porcine reproductive respiratory syndrome virus inactivated vaccine based on the viral quantity and inactivation methods.
    Kim H; Kim HK; Jung JH; Choi YJ; Kim J; Um CG; Hyun SB; Shin S; Lee B; Jang G; Kang BK; Moon HJ; Song DS
    Virol J; 2011 Jun; 8():323. PubMed ID: 21703032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of vaccination with a modified-live porcine reproductive and respiratory syndrome virus vaccine on dynamics of homologous viral infection in pigs.
    Cano JP; Dee SA; Murtaugh MP; Trincado CA; Pijoan CB
    Am J Vet Res; 2007 May; 68(5):565-71. PubMed ID: 17472459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology.
    Kimman TG; Cornelissen LA; Moormann RJ; Rebel JM; Stockhofe-Zurwieden N
    Vaccine; 2009 Jun; 27(28):3704-18. PubMed ID: 19464553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
    Evenson D; Gerber PF; Xiao CT; Halbur PG; Wang C; Tian D; Ni YY; Meng XJ; Opriessnig T
    Vaccine; 2016 Nov; 34(46):5546-5553. PubMed ID: 27742217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of modified-live porcine reproductive and respiratory syndrome virus (PRRSv) vaccine on the shedding of wild-type virus from an infected population of growing pigs.
    Linhares DC; Cano JP; Wetzell T; Nerem J; Torremorell M; Dee SA
    Vaccine; 2012 Jan; 30(2):407-13. PubMed ID: 22063389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Negative impact of porcine reproductive and respiratory syndrome virus infection on the efficacy of classical swine fever vaccine.
    Suradhat S; Kesdangsakonwut S; Sada W; Buranapraditkun S; Wongsawang S; Thanawongnuwech R
    Vaccine; 2006 Mar; 24(14):2634-42. PubMed ID: 16406169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction and evaluation of genetically engineered replication-defective porcine reproductive and respiratory syndrome virus vaccine candidates.
    Welch SK; Jolie R; Pearce DS; Koertje WD; Fuog E; Shields SL; Yoo D; Calvert JG
    Vet Immunol Immunopathol; 2004 Dec; 102(3):277-90. PubMed ID: 15507311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.